.jpg)
Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
International peptide transport requires three core documents: (1) an institutional authorization letter signed by a principal investigator specifying the compound, quantity, and research purpose
CAS Number 2381089-83-2 Molecular Weight 4731.33 Da Molecular Formula CHNO Class GIP/GLP-1/Glucagon Triple Receptor Agonist Research context
While short-term use under supervision may be tolerated, extended use could pose unknown risks
According to UK research findings, the health benefits of peptide blends include improved muscle gain, accelerated weight loss, higher bone density, increased libido, and a strengthened immune system, among other health benefits
It is identified in the clinical-research literature under the development designation LY3437943 and is currently in Phase 3 evaluation under the TRIUMPH trial program
US$ 23.98
US$ 29.61
US$ 20.41
US$ 24.56
US$ 23.90
US$ 27.94
